Properties
                                        
                            Description
                            GSK 269962 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity. It targets AKT1, AKT2, AKT3, and CDK2.
                         
                                                                            
                                                            
                            Molecular Formula
                            C29H30N8O5
                         
                                                                                                                                            
                            Targets
                            AKT1: 955 nM; AKT2: 1350 nM; AKT3: 1510 nM; CDK2: 3500 nM
                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                            
                                                                                                                                                                                            
                            Identity
                            Confirmed by NMR/HPLC/MS.
                         
                                                                                                                                                            
                            Applications
                            GSK 269962 is utilized to study its inhibitory effects on Rho-associated protein kinases (ROCK1/2) in cell mobility research.